Peptides
Structured profiles: evidence by tier, registry identifiers, risks and regulatory status per jurisdiction.
Browse the libraryEvery claim on this site is labelled with the kind of study behind it and linked to its source. Where the evidence runs out, we say so.
Each one an entity page, not an article
of 18 catalogued
220 conducted in humans
Across 8 research areas
Start here
The library holds the structured evidence, the areas group it by goal, the articles work through it, and the methodology explains how any of it was judged.
Structured profiles: evidence by tier, registry identifiers, risks and regulatory status per jurisdiction.
Browse the libraryEight research areas: recovery, performance, sleep, longevity, cognition, weight, skin and safety.
Explore topicsEvidence reviews and comparisons, each built from the primary literature and citing every source.
Read articlesHow sources are chosen, what each evidence label means, and the claims this site refuses to make.
Our processOur approach
Every claim carries the kind of study behind it and a link to that study. Eight tiers collapse into three bands, so you know what a claim rests on before you read it.
Measured in people under controlled conditions. The only kind of evidence that can show a substance works in humans.
ExamplesRandomised trials, meta-analyses
Measured in animals, cells or tissue. Often where a promising idea starts, and frequently where it stops.
ExamplesRodent models, cell studies
A plausible biological story, or someone’s report. Neither is a measured outcome.
ExamplesProposed mechanisms, self-reports
Structured evidence, registry identifiers and regulatory status per jurisdiction, for each compound.
Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH
A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.
BPC 157, PL-14736, PL 14736, PLD-116, PL-10, Bepecin, pentadecapeptide BPC 157
A 15-amino-acid fragment of a gastric juice protein, studied mostly in rats for tendon and muscle healing. No randomised trial has shown a benefit in people.
CJC-1295 DAC, DAC:GRF
A synthetic analogue of growth hormone-releasing hormone. Two molecules share the name; only one was studied in people, for hormone levels.
PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, Hexanoyl-Tyr-Ile-Ahx-NH2, ATH-1001
A synthetic angiotensin IV analogue with no human study found. Its mechanism paper was retracted in 2025; FDA lists it as a withdrawn compounding nomination.
Explore by goal
Eight areas, each one a hub linking the peptides studied for it and the evidence reviews written about it.
Memory, focus and neuroprotection, and how far the research gets to real endpoints.
4 peptides
The one area with large randomised trials and approved medicines, next to ones without.
4 peptides
Adverse effects, product quality, and legal status across the major jurisdictions.
12 peptides
Safety
No regulator document found approves selank. What FDA, Health Canada and New Zealand's Medsafe have said about selling, importing and holding it.
Methodology
Cells, rats or people? Controls, sample size, lab markers, spin, sponsors, retractions and unposted trials, with real peptide examples.
Explainer
Peptides are short chains of amino acids. Some are hormones, dozens are approved drugs worldwide, and many sold as research peptides have no FDA approval.